TITLE

Generic Drugmakers Garner M&A Interest

AUTHOR(S)
Collins, Allison; Diakantonis, Demitri
PUB. DATE
January 2016
SOURCE
Mergers & Acquisitions: The Dealermaker's Journal;Jan2016, Vol. 51 Issue 1, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the active participation of dealmakers in the generic drug-making industry, which underscored by the merger and acquisition (M&A) activity from Perrigo Co. PLC, Cardinal Health Inc., Mylan NV, and Teva.
ACCESSION #
111934504

 

Related Articles

  • Pharma: Other News To Note.  // BioWorld Today;1/ 2/2013, Vol. 24 Issue 1, p4 

    The article reports on the merger agreement signed by Perrigo Co. of Allen, Michigan to acquire Chicago, Illinois-based Cobrek Pharmaceuticals Inc. for $45 million.

  • Mylan. Investor's Business Daily // Investors Business Daily;7/30/2015, pA02 

    The article reports on the announcement of pharmaceutical firm Mylan NV that it has received approval from regulations in Europe to push through with its proposal to aquire healthcare supplier Perrigo Co. PLC.

  • Abbott Affirms its Support for Mylan's proposed acquisition of Perrigo.  // eHEALTH;6/18/2015, p1 

    The article reports that global healthcare company Abbott has confirmed that it will continue support for pharmaceutical firm Mylan NV's growth strategy by stating its intent to support Mylan's proposed acquisition of pharmaceutical firm Perrigo. Topics include Abbott's intent to vote its 14.5...

  • OPINION.  // Crain's Detroit Business;11/16/2015, Vol. 31 Issue 46, p0008 

    In the article, the author discusses economic and business developments in Michigan as of mid-November 2015. Based on the Business Leaders of Michigan benchmarking report, Michigan is number 46 in terms of annual unemployment in the U.S., number 36 in per capita income, and 34th in per capita...

  • Mylan Offers Perrigo $29 Bil. Investor's Business Daily // Investors Business Daily;4/9/2015, pA01 

    2 Unsolicited, the generic drugmaker bid $205 a share to buy

  • Hostile And Hopeful Teva Offers $40 Bil For Mylan. AMY REEVES // Investors Business Daily;4/22/2015, pA01 

    The article focuses on the $40 billion bid of Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. to acquire its competitor Mylan NV, which also shows interest to buy generic drug maker Perrigo Co. LLC. The stand of Mylan on Teva's acquisition bid is discussed. Also explained is...

  • Bergen Brunswig, Cardinal joining forces.  // Drug Topics;9/1/97, Vol. 141 Issue 17, p7 

    Reports in September 1997 that the drug wholesaling companies Cardinal Health and Bergen Brunswig have entered into a definitive merger agreement. Name of the combined entity; Products that the entity will be able to offer; Name of the persons that fill top management posts.

  • Cardinal reports record revenues.  // Drug Store News;2/19/2001, Vol. 23 Issue 2, p24 

    Focuses on the record revenues earned by pharmaceutical company Cardinal Heath for the second quarter ended December 31, 2000. Increase in the net earnings of the company; Implications of the increased earnings to its operations; Plan of the company to acquire Bindley Western company.

  • Year of transformation reinvigorates Cardinal.  // Chain Drug Review;7/18/2011, Vol. 33 Issue 12, p57 

    The article reports on the strategic plan of the pharmaceutical wholesaler Cardinal Health Inc. in the U.S. in 2011. It mentions the company's acquisitions of the Healthcare Solutions Holding and Zuellig Pharma to expand its distribution business. According to Cardinal's chairman and chief...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics